| review article | Q7318358 |
| scholarly article | Q13442814 |
| P50 | author | Myron M. Levine | Q29564379 |
| P2093 | author name string | Sharon M. Tennant | |
| P2860 | cites work | Vaccines against invasive Salmonella disease: current status and future directions | Q27007088 |
| One-step inactivation of chromosomal genes in Escherichia coli K-12 using PCR products | Q27860842 | ||
| Macrophage-dependent induction of the Salmonella pathogenicity island 2 type III secretion system and its role in intracellular survival | Q27976514 | ||
| Ty21a live oral typhoid vaccine and prevention of paratyphoid fever caused by Salmonella enterica Serovar Paratyphi B | Q28307137 | ||
| A randomised trial evaluating the safety and immunogenicity of the novel single oral dose typhoid vaccine M01ZH09 in healthy Vietnamese children | Q28474905 | ||
| SseBCD proteins are secreted by the type III secretion system of Salmonella pathogenicity island 2 and function as a translocon | Q28490029 | ||
| Immune response induced by Salmonella typhimurium defective in ppGpp synthesis | Q46852567 | ||
| Salmonella enteritidis temperature-sensitive mutants protect mice against challenge with virulent Salmonella strains of different serotypes | Q50118967 | ||
| Comparison of the abilities of Salmonella typhimurium rpoS, aroA and rpoS aroA strains to elicit humoral immune responses in BALB/c mice and to cause lethal infection in athymic BALB/c mice | Q50126289 | ||
| Identification of a pathogenicity island required for Salmonella enteropathogenicity | Q50129531 | ||
| Correlates of protection induced by live Aro- Salmonella typhimurium vaccines in the murine typhoid model | Q50134874 | ||
| Safety, efficacy, and duration of immunity induced in swine by use of an avirulent live Salmonella choleraesuis-containing vaccine | Q50145980 | ||
| Safety and immunogenicity of Salmonella typhi Ty21a liquid formulation vaccine in 4- to 6-year-old Thai children | Q50174133 | ||
| Evaluation of Salmonella typhimurium strains harbouring defined mutations in htrA and aroA in the murine salmonellosis model | Q50180559 | ||
| Clinical acceptability and immunogenicity of CVD 908 Salmonella typhi vaccine strain | Q50181478 | ||
| Genetic manipulation of Salmonella serotype Bovismorbificans to aromatic-dependence and evaluation of its vaccine potential in mice | Q50190870 | ||
| Virulence and vaccine potential of phoP mutants of Salmonella typhimurium | Q50195223 | ||
| A Salmonella locus that controls resistance to microbicidal proteins from phagocytic cells | Q50195971 | ||
| Control of colonization by virulent Salmonella typhimurium by oral immunization of chickens with avirulent delta cya delta crp S. typhimurium. | Q50464130 | ||
| Construction of genetically defined double aro mutants of Salmonella typhi | Q40743402 | ||
| Comparison of enteric-coated capsules and liquid formulation of Ty21a typhoid vaccine in randomised controlled field trial | Q40757649 | ||
| Large-scale field trial of Ty21a live oral typhoid vaccine in enteric-coated capsule formulation | Q40797037 | ||
| Cellular immunity induced by avirulent Salmonella in LPS-defective C3H/HeJ mice | Q40825674 | ||
| Isolation and Characterization of Gal E Mutant Ty 21a of Salmonella typhi: A Candidate Strain for a Live, Oral Typhoid Vaccine | Q40897058 | ||
| Mouse models for assessing the cross-protective efficacy of oral non-typhoidal Salmonella vaccine candidates harbouring in-frame deletions of the ATP-dependent protease lon and other genes. | Q41544254 | ||
| Safety and tolerability of a live oral Salmonella typhimurium vaccine candidate in SIV-infected nonhuman primates | Q42264370 | ||
| The role of a stress-response protein in Salmonella typhimurium virulence | Q42612990 | ||
| Immunity conferred by Aro- Salmonella live vaccines | Q43719325 | ||
| Protection against oral challenge three months after i.v. immunization of BALB/c mice with live Aro Salmonella typhimurium and Salmonella enteritidis vaccines is serotype (species)-dependent and only partially determined by the main LPS O antigen | Q43740292 | ||
| Suisaloral "Dessau"--a Salmonella cholerae suis live vaccine for oral, parenteral and combined applications | Q44067086 | ||
| Turnover of FlhD and FlhC, master regulator proteins for Salmonella flagellum biogenesis, by the ATP-dependent ClpXP protease | Q44390470 | ||
| Gene replacement without selection: regulated suppression of amber mutations in Escherichia coli | Q44508201 | ||
| Biological and virulence characteristics of Salmonella enterica serovar Typhimurium following deletion of glucose-inhibited division (gidA) gene. | Q45986810 | ||
| Evaluation of Salmonella enterica serovar Typhi (Ty2 aroC-ssaV-) M01ZH09, with a defined mutation in the Salmonella pathogenicity island 2, as a live, oral typhoid vaccine in human volunteers | Q46685348 | ||
| Genes encoding putative effector proteins of the type III secretion system of Salmonella pathogenicity island 2 are required for bacterial virulence and proliferation in macrophages | Q28563572 | ||
| Immunology of Gut Mucosal Vaccines | Q28972559 | ||
| Signatures of adaptation in human invasive Salmonella Typhimurium ST313 populations from sub-Saharan Africa. | Q30372980 | ||
| Novel attenuated Salmonella enterica serovar Choleraesuis strains as live vaccine candidates generated by signature-tagged mutagenesis | Q30802772 | ||
| Salmonella DNA adenine methylase mutants confer cross-protective immunity | Q33552366 | ||
| The delicate balance in genetically engineering live vaccines | Q33801051 | ||
| Attenuation and immunogenicity of Deltacya Deltacrp derivatives of Salmonella choleraesuis in pigs | Q34001774 | ||
| In vivo characterization of the murine intranasal model for assessing the immunogenicity of attenuated Salmonella enterica serovar Typhi strains as live mucosal vaccines and as live vectors | Q34003031 | ||
| Phase 2 clinical trial of attenuated Salmonella enterica serovar typhi oral live vector vaccine CVD 908-htrA in U.S. volunteers | Q34003500 | ||
| Constitutive expression of the Vi polysaccharide capsular antigen in attenuated Salmonella enterica serovar typhi oral vaccine strain CVD 909 | Q34007802 | ||
| Roles of DNA adenine methylation in regulating bacterial gene expression and virulence | Q34009521 | ||
| Characterization of Salmonella enterica derivatives harboring defined aroC and Salmonella pathogenicity island 2 type III secretion system (ssaV) mutations by immunization of healthy volunteers. | Q34125990 | ||
| Invasive non-typhoidal salmonella disease: an emerging and neglected tropical disease in Africa. | Q34275116 | ||
| A two-component regulatory system (phoP phoQ) controls Salmonella typhimurium virulence. | Q34286908 | ||
| Salmonella typhimurium phoP virulence gene is a transcriptional regulator | Q34303992 | ||
| The HtrA family of serine proteases | Q34447737 | ||
| Immunological characterization of a gidA mutant strain of Salmonella for potential use in a live-attenuated vaccine | Q34495624 | ||
| Safety and immunogenicity of Salmonella typhi Ty21a vaccine in young Thai children. | Q34528102 | ||
| Evaluation of Salmonella enterica serovar Typhimurium TTSS-2 deficient fur mutant as safe live-attenuated vaccine candidate for immunocompromised mice | Q34532843 | ||
| Immunization to protect the US Armed Forces: heritage, current practice, and prospects | Q34536318 | ||
| Further characterization of the PhoP regulon: identification of new PhoP-activated virulence loci | Q34545309 | ||
| Sustained protection in mice immunized with fractional doses of Salmonella Enteritidis core and O polysaccharide-flagellin glycoconjugates. | Q34760675 | ||
| Cross-protection against Salmonella Typhimurium infection conferred by a live attenuated Salmonella Enteritidis vaccine | Q34813377 | ||
| Invasive Salmonella Typhimurium ST313 with naturally attenuated flagellin elicits reduced inflammation and replicates within macrophages | Q34874212 | ||
| Salmonella enterica serovar enteritidis core O polysaccharide conjugated to H:g,m flagellin as a candidate vaccine for protection against invasive infection with S. enteritidis | Q35272921 | ||
| Effect of deletion of genes involved in lipopolysaccharide core and O-antigen synthesis on virulence and immunogenicity of Salmonella enterica serovar typhimurium | Q35273125 | ||
| Engineering and preclinical evaluation of attenuated nontyphoidal Salmonella strains serving as live oral vaccines and as reagent strains | Q35273267 | ||
| Non-typhoidal Salmonella Typhimurium ST313 isolates that cause bacteremia in humans stimulate less inflammasome activation than ST19 isolates associated with gastroenteritis | Q35443593 | ||
| Effect of vaccination of hens with an avirulent strain of Salmonella typhimurium on immunity of progeny challenged with wild-Type Salmonella strains. | Q35475498 | ||
| Characterization and immunogenicity of Salmonella typhimurium SL1344 and UK-1 delta crp and delta cdt deletion mutants | Q35561471 | ||
| Evaluation in volunteers of a candidate live oral attenuated Salmonella typhi vector vaccine | Q35604978 | ||
| DNA adenine methylase mutants of Salmonella typhimurium show defects in protein secretion, cell invasion, and M cell cytotoxicity | Q35657182 | ||
| Enterobacterial common antigen mutants of Salmonella enterica serovar Typhimurium establish a persistent infection and provide protection against subsequent lethal challenge | Q35665380 | ||
| Salmonella enterica serotype Choleraesuis: epidemiology, pathogenesis, clinical disease, and treatment | Q35745827 | ||
| Live oral typhoid vaccine Ty21a induces cross-reactive humoral immune responses against Salmonella enterica serovar Paratyphi A and S. Paratyphi B in humans | Q36017715 | ||
| Transport of antibiotics and metabolite analogs by systems under cyclic AMP control: positive selection of Salmonella typhimurium cya and crp mutants | Q36417093 | ||
| Vaccination against typhoid fever: present status | Q36794750 | ||
| CVD 908, CVD 908-htrA, and CVD 909 live oral typhoid vaccines: a logical progression | Q36854777 | ||
| Characterization and protective properties of attenuated mutants of Salmonella choleraesuis | Q36971527 | ||
| A galE via (Vi antigen-negative) mutant of Salmonella typhi Ty2 retains virulence in humans | Q37005140 | ||
| Salmonella typhimurium deletion mutants lacking adenylate cyclase and cyclic AMP receptor protein are avirulent and immunogenic | Q37009163 | ||
| Attenuating gene expression (AGE) for vaccine development | Q37021492 | ||
| Immunity to Salmonella typhimurium infection in C3H/HeJ and C3H/HeNCrlBR mice: studies with an aromatic-dependent live S. typhimurium strain as a vaccine | Q37035685 | ||
| Oral immunization: an update | Q37362149 | ||
| Identification of a pathogenicity island required for Salmonella survival in host cells | Q37441337 | ||
| Epidemic multiple drug resistant Salmonella Typhimurium causing invasive disease in sub-Saharan Africa have a distinct genotype | Q37471898 | ||
| M-01ZH09, an oral live attenuated Salmonella enterica serovar Typhi vaccine for the prevention of typhoid fever. | Q37609003 | ||
| Live oral Salmonella enterica serovar Typhi vaccines Ty21a and CVD 909 induce opsonophagocytic functional antibodies in humans that cross-react with S. Paratyphi A and S. Paratyphi B | Q37643333 | ||
| Identification of a virulence locus encoding a second type III secretion system in Salmonella typhimurium | Q37698755 | ||
| Increasing rates of Salmonella Paratyphi A and the current status of its vaccine development | Q38140038 | ||
| Salmonella DNA adenine methylase mutants elicit protective immune responses to homologous and heterologous serovars in chickens | Q38455796 | ||
| Progress in vaccines against typhoid fever | Q38675526 | ||
| Characterization of candidate live oral Salmonella typhi vaccine strains harboring defined mutations in aroA, aroC, and htrA. | Q39509638 | ||
| Aromatic-dependent Salmonella typhimurium are non-virulent and effective as live vaccines | Q39513114 | ||
| Immunological responses induced by asd and wzy/asd mutant strains of Salmonella enterica serovar Typhimurium in BALB/c mice | Q39662683 | ||
| The ClpXP ATP-dependent protease regulates flagellum synthesis in Salmonella enterica serovar typhimurium. | Q39694510 | ||
| Safety of live oral Salmonella typhi vaccine strains with deletions in htrA and aroC aroD and immune response in humans. | Q39827320 | ||
| Salmonella typhimurium loci involved in survival within macrophages | Q39860005 | ||
| Comparison of the safety and immunogenicity of delta aroC delta aroD and delta cya delta crp Salmonella typhi strains in adult volunteers | Q40149266 | ||
| Test of the virulence and live-vaccine efficacy of auxotrophic and galE derivatives of Salmonella choleraesuis | Q40162957 | ||
| Live oral typhoid vaccine Salmonella Typhi Ty21a - a surrogate vaccine against non-typhoid salmonella? | Q40270837 | ||
| Reactogenicity and immunogenicity of live attenuated Salmonella enterica serovar Paratyphi A enteric fever vaccine candidates | Q40363040 | ||
| In a randomized, double-blinded, placebo-controlled trial, the single oral dose typhoid vaccine, M01ZH09, is safe and immunogenic at doses up to 1.7 x 10(10) colony-forming units | Q40365149 | ||
| Genetic stability of vaccine strain Salmonella Typhi Ty21a over 25 years | Q40400330 | ||
| Comparison of the antibodies in lymphocyte supernatant and antibody-secreting cell assays for measuring intestinal mucosal immune response to a novel oral typhoid vaccine (M01ZH09). | Q40499187 | ||
| The novel oral typhoid vaccine M01ZH09 is well tolerated and highly immunogenic in 2 vaccine presentations | Q40504663 | ||
| Immune responses to an oral typhoid vaccine strain that is modified to constitutively express Vi capsular polysaccharide | Q40530217 | ||
| ppGpp-dependent stationary phase induction of genes on Salmonella pathogenicity island 1. | Q40552048 | ||
| An essential role for DNA adenine methylation in bacterial virulence | Q40639021 | ||
| Virulence and vaccine potential of Salmonella typhimurium mutants deficient in the expression of the RpoS (sigma S) regulon | Q40663159 | ||
| phoP/phoQ-deleted Salmonella typhi (Ty800) is a safe and immunogenic single-dose typhoid fever vaccine in volunteers. | Q40668237 | ||
| Attenuated Salmonella as live oral vaccines against typhoid fever and as live vectors | Q40673098 | ||
| The PhoP virulence regulon and live oral Salmonella vaccines. | Q40723116 | ||
| The effect of exposure to a Δcya/ Δcrp mutant of Salmonella typhimurium on the subsequent colonization of swine by the wild-type parent strain | Q40732924 | ||
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | attenuated vaccine | Q1810913 |
| P304 | page(s) | C36-41 | |
| P577 | publication date | 2015-06-19 | |
| P1433 | published in | Vaccine | Q7907941 |
| P1476 | title | Live attenuated vaccines for invasive Salmonella infections | |
| P478 | volume | 33 Suppl 3 |
| Q47897645 | A brief review on the immunological scenario and recent developmental status of vaccines against enteric fever |
| Q46396572 | A novel live attenuated anthrax spore vaccine based on an acapsular Bacillus anthracis Sterne strain with mutations in the htrA, lef and cya genes |
| Q38896014 | Animal Models for Salmonellosis: Applications in Vaccine Research |
| Q61818475 | Attenuated Salmonella Typhimurium expressing Salmonella Paratyphoid A O-antigen induces protective immune responses against two Salmonella strains |
| Q36824195 | Building the case for wider use of typhoid vaccines |
| Q98243754 | Common bacterial, viral, and parasitic diseases in pigeons (Columba livia): A review of diagnostic and treatment strategies |
| Q50895040 | Contagion 2.0. |
| Q89176447 | Deletions in guaBA and htrA but not clpX or rfaL constitute a live-attenuated vaccine strain of Salmonella Newport to protect against serogroup C2-C3 Salmonella in mice |
| Q38955147 | Detection of Typhoidal and Paratyphoidal Salmonella in Blood by Real-time Polymerase Chain Reaction. |
| Q93102673 | Dietary Fatty Acids and Host-Microbial Crosstalk in Neonatal Enteric Infection |
| Q90533031 | Effective mucosal live attenuated Salmonella vaccine by deleting phosphotransferase system component genes ptsI and crr |
| Q47127930 | Evaluation of Recombinant Attenuated Salmonella Vaccine Strains for Broad Protection against Extraintestinal Pathogenic Escherichia coli |
| Q58719828 | HU-Lacking Mutants of Enteritidis Are Highly Attenuated and Can Induce Protection in Murine Model of Infection |
| Q89621245 | Humoral Immunity vs. Salmonella |
| Q104504775 | Immunogenicity and protection efficacy of a Salmonella enterica serovar Typhimurium fnr, arcA and fliC mutant |
| Q38663493 | Intracellular Salmonella metabolism. |
| Q91595626 | Investigation of the role of typhoid toxin in acute typhoid fever in a human challenge model |
| Q37429384 | Live Attenuated Human Salmonella Vaccine Candidates: Tracking the Pathogen in Natural Infection and Stimulation of Host Immunity |
| Q62486559 | Nonspecific effects of oral vaccination with live-attenuated Typhi strain Ty21a |
| Q47103827 | O-Serotype Conversion in Salmonella Typhimurium Induces Protective Immune Responses against Invasive Non-Typhoidal Salmonella Infections |
| Q89883532 | Oral Deliverable Mucoadhesive Chitosan-Salmonella Subunit Nanovaccine for Layer Chickens |
| Q98160154 | Review on the Recent Advances on Typhoid Vaccine Development and Challenges Ahead |
| Q58600076 | Rewiring of one carbon metabolism in Salmonella serves as an excellent live vaccine against systemic salmonellosis |
| Q28354066 | Role of T3SS-1 SipD Protein in Protecting Mice against Non-typhoidal Salmonella Typhimurium |
| Q38727040 | Salmonella Co-opts Host Cell Chaperone-mediated Autophagy for Intracellular Growth |
| Q28388835 | Salmonella Serogroup C: Current Status of Vaccines and Why They Are Needed |
| Q49644946 | Salmonella Vaccines: Conduits for Protective Antigens |
| Q40448733 | TIR-Domain-Containing Adapter-Inducing Interferon-β (TRIF) Regulates CXCR5+ T helper Cells in the Intestine. |
| Q49934646 | The role of ATP pools in persister cell formation in (fluoro)quinolone-susceptible and -resistant strains of Salmonella enterica ser. Typhimurium |
| Q36764359 | Toll-Like Receptor Activation by Generalized Modules for Membrane Antigens from Lipid A Mutants of Salmonella enterica Serovars Typhimurium and Enteritidis |
| Q41475755 | Two Novel Salmonella Bivalent Vaccines Confer Dual Protection against Two Salmonella Serovars in Mice |
| Q92708730 | Unexpected Role of CD8 T Cells in Accelerated Clearance of Salmonella enterica Serovar Typhimurium from H-2 Congenic mice |
| Q40040654 | Use of a novel antigen expressing system to study the Salmonella enterica serovar Typhi protein recognition by T cells. |
| Q39373957 | Vaccination against Salmonella Infection: the Mucosal Way. |
| Q40544564 | Zebrafish as a novel model for non-typhoidal Salmonella pathogenesis, transmission and vaccine efficacy |
| Q93173167 | ptsI gene in the phosphotransfer system is a potential target for developing a live attenuated Salmonella vaccine |
Search more.